Literature DB >> 25667743

Aspergillus keratitis after deep anterior lamellar keratoplasty.

Afshin Lotfi Sadigh1, Abdollah Shenasi1, Seyed Ziaeddin Mortazavi1, Seyed Mohammad Morsali2.   

Abstract

Entities:  

Year:  2014        PMID: 25667743      PMCID: PMC4307653          DOI: 10.4103/2008-322X.143383

Source DB:  PubMed          Journal:  J Ophthalmic Vis Res        ISSN: 2008-322X


× No keyword cloud information.
A 17-year-old female with a several-year history of bilateral keratoconus was visited about 1 year prior to deep anterior lamellar keratoplasty (DALK) in her right eye (OD). History-wise, she was intolerant to glasses and contact lenses and her past medical history and family history were unremarkable. On ocular examination, she had visual acuity (VA) of 2 meters counting fingers (CF) in each eye without correction and 4 meters CF after best spectacle correction of −17.50−5.0× 10° and −12.50ͨ5.0× 165° in the right and left eyes, respectively. Slit lamp biomicroscopy showed normal ocular adnexa but bulged clear corneas with typical signs of keratoconus in both eyes. Remaining ocular examinations in both eyes were unremarkable. The patient underwent DALK in her right eye; a recipient corneal bed size of 7.50 mm received a 7.75 mm graft, which was preserved in optisol solution and had been obtained from a 39-year-old male donor died from trauma. Death to preservation time was about 27 h and the time interval between graft preservation and DALK was 3 days. After removing its endothelium, the donor cornea was sutured to the recipient bed using 10-0 nylon double running torque-antitorque method. At the end of the surgery, subconjunctival injection of betamethasone-cephazolin was given without placing a bandage contact lens on the cornea. Postoperatively, the patient received betamethasone eye drops (every 4 hours), chloramphenicol eye drops (every 6 hours) and preservative-free artificial tears (every 2 hours). One week post operatively, the patient was found to have moderately red right eye and on examination, mild melting of the graft was observed at 12-1.50 o’clock position. The double running sutures seemed a little tight; however, no gross infiltration was noted and the anterior chamber did not show apparent cellular reaction. Subsequently, frequency of the lubricant eye drops was increased, however her ocular findings did not improve much after 3 days. In order to prevent corneal drying and provide better lubrication, lateral blepharorrhaphy was done for the right eye. One week later, she was found to have interface infiltration and increased graft melting at the same site described above. The patient was soon admitted to the hospital and after taking routine cultures, was started on fortified vancomycin and ceftazidime drops. One week later, patient's eye condition got worse and melting involved the whole graft [Figure 1]. Meanwhile, the first culture was reported negative for bacteria and fungi.
Figure 1

Right eye of the patient 3 weeks after deep anterior lamellar keratoplasty.

Right eye of the patient 3 weeks after deep anterior lamellar keratoplasty. Three weeks after surgery, the patient underwent a second surgery, therapeutic penetrating keratoplasty, during which routine cultures were repeated and the excised graft tissue was sent for histopathalogic and microbiologic exams. The culture was reported positive for aspergillus on the 2nd postoperative day when amphotricin B 0.2% drops every hour and oral itraconazole 100 mg twice daily were started for the patient. One week after initiation of antifungal therapy, the improvement was so drastic that the patient was discharged from the hospital [Figure 2], with maintenance dosage of systemic and local antifungal agents which was gradually tapered over the following 2 months. Three months after DALK [Figure 3], the patient had a quiet eye with uncorrected VA of 3/10 and signs of cataract development; intraocular pressure of the eye was 16 mmHg at this visit.
Figure 2

Right eye of the patient 1 week after therapeutic penetrating keratoplasty and antifungal therapy.

Figure 3

Histopathologic report of the excised graft was positive for aspergillus.

Right eye of the patient 1 week after therapeutic penetrating keratoplasty and antifungal therapy. Histopathologic report of the excised graft was positive for aspergillus.

DISCUSSION

Fungal keratitis is one of the most difficult forms of microbial keratitis for the ophthalmologist to diagnose and treat successfully.[1] Corneal transplantation is one of the risk factors for fungal (Candida) keratitis and concurrent administration of topical steroids increases the risk of infection.[234] It is an uncommon event after penetrating keratoplasty.[23456] There are several reports indicating that the risk of donor-to-host transmission is 12-22 times greater when a donor cornea with a positive rim culture is transplanted.[57] The odds of fungal endophthalmitis with a fungal culture-positive donor rim are 247 times greater than with fungal culture-negative donor rim.[47] Kitzmann et al, have adopted a new practice of empirically treating all patients who have fungal positive donor corneoscleral rims with topical 0.15% amphotricin B, 4 times/day and oral fluconazole 200 mg twice a day, for 4 weeks.[7] They routinely take donor corneoscleral rim cultures in all keratoplasty cases whereas this routine is not practiced by many corneal surgeons including us. The reported cases of fungal keratitis in the setting of DALK and Descemet's stripping automated endothelial keratoplasty surgeries are confined to about 10 articles (PubMed search on March 2013) and interestingly all of them were due to Candida species[34567891011] except for one that was due to aspergillus.[12] Our case may be the second one. In all reported cases, documentation of the infection was made by culture. Likewise, our case had positive culture for aspergillus, in addition to histopathalogic report [Figure 4] from the removed infected graft tissue. This shows the importance of microbiologic and histopathalogic examination of the tissues excised by ophthalmologist even if the clinical picture of the patient is not in favor of fungal infection.
Figure 4

Fungal mycelium (septate type) in the infected cornea.

Fungal mycelium (septate type) in the infected cornea. In six articles, which reported DALK cases with fungal infection,[358101112] all but two, had the clinical findings of infection at least 4 weeks postoperatively with gradual progression.[35810] In the remaining two articles, the clinical findings were in the early postoperative period,[1112] implicating the aggressive behavior of the fungal agent. One of them was documented to be due to aspergillus[12] and the other due to Candida.[11] Similarly, our case showed abnormal findings in the early postoperative period. This short period of time for onset and progression of a fungal infection may be attributed to the aggressive behavior of fungal agents when they occur in a setting which provides a potential space for their rapid growth (the DALK interface potential space). In summary, fungal infection after DALK surgery should be considered among the differential diagnosis in patients who present with interface infiltrate and corneal melting even in the early postoperative period. The practice of taking donor corneoscleral rim culture as Kitzmann et al[7] routinely perform in keratoplasty cases at the time of surgery, is greatly appreciated and logical, and may be a necessity as new cases of misleading fungal infections arise in the setting of new techniques of modern keratoplasty.
  11 in total

1.  Interface fungal keratitis after endothelial keratoplasty: a clinicopathological report.

Authors:  W Barry Lee; J Brian Foster; Alan M Kozarsky; Qing Zhang; Hans E Grossniklaus
Journal:  Ophthalmic Surg Lasers Imaging       Date:  2011-04-14

2.  The incidence of fungal keratitis and endophthalmitis following penetrating keratoplasty.

Authors:  Kayvan Keyhani; John A Seedor; Mahendra K Shah; Anthony J Terraciano; David C Ritterband
Journal:  Cornea       Date:  2005-04       Impact factor: 2.651

3.  Candida interface keratitis following deep anterior lamellar keratoplasty.

Authors:  Ayse E Bahadir; Tahir K Bozkurt; Selda Aktay Kutan; Cemil A Yanyali; Suphi Acar
Journal:  Int Ophthalmol       Date:  2012-03-27       Impact factor: 2.031

4.  Late-onset Candida keratitis after Descemet stripping automated endothelial keratoplasty: clinical and confocal microscopic report.

Authors:  Amanda Ortiz-Gomariz; Alejandro Higueras-Esteban; Ángel Ramón Gutiérrez-Ortega; José M González-Méijome; Angeles Arance-Gil; César Villa-Collar
Journal:  Eur J Ophthalmol       Date:  2011 Jul-Aug       Impact factor: 2.597

5.  Donor-related Candida keratitis after Descemet stripping automated endothelial keratoplasty.

Authors:  Anna S Kitzmann; Michael D Wagoner; Nasreen A Syed; Kenneth M Goins
Journal:  Cornea       Date:  2009-08       Impact factor: 2.651

6.  Fungal interface keratitis by Candida orthopsilosis following deep anterior lamellar keratoplasty.

Authors:  Julia M Wessel; Björn O Bachmann; Ralph Meiller; Friedrich E Kruse
Journal:  BMJ Case Rep       Date:  2013-01-23

7.  Candida interface keratitis after deep anterior lamellar keratoplasty: clinical, microbiologic, histopathologic, and confocal microscopic reports.

Authors:  Mozhgan Rezaei Kanavi; Ali Reza Foroutan; Mohsen Rahmati Kamel; Nikoo Afsar; Mohammad Ali Javadi
Journal:  Cornea       Date:  2007-09       Impact factor: 2.651

8.  Candida albicans interface infection after deep anterior lamellar keratoplasty.

Authors:  Luigi Fontana; Gabriella Parente; Bruna Di Pede; Giorgio Tassinari
Journal:  Cornea       Date:  2007-08       Impact factor: 2.651

9.  Candida keratitis after descemet stripping and automated endothelial keratoplasty.

Authors:  Steven B Koenig; William J Wirostko; Robert I Fish; Douglas J Covert
Journal:  Cornea       Date:  2009-05       Impact factor: 2.651

10.  Aspergillus flavus keratitis after deep anterior lamellar keratoplasty.

Authors:  Mohammad-Reza Jafarinasab; Sepehr Feizi; Forouzan Yazdizadeh; Mozhgan Rezaei Kanavi; Hamid-Reza Moein
Journal:  J Ophthalmic Vis Res       Date:  2012-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.